论文部分内容阅读
目的探讨和调查卵巢癌化疗期患者心理健康状况及其对策。方法回顾性分析2011年1月-2013年6月期间广州市中西医结合医院确诊治疗的卵巢癌患者89例的临床资料,采用焦虑自评量表(SAS)评估焦虑状态,采用抑郁自评量表(SDS)评估抑郁状态,依据焦虑状态分为焦虑组和A组,依据抑郁焦虑状态分为抑郁组和B组,随访3年,统计分析所有患者化疗期间的心理健康状况和生存情况。结果本次调查中,有焦虑情绪者62例,焦虑率为69.63%,有抑郁情绪者49例,抑郁率为55.06%,焦虑组患者3年生存率、中位生存期均明显低于A组,差异有统计学意义(P<0.05);抑郁组患者3年生存率、中位生存期均明显低于B组,差异有统计学意义(P<0.05)。结论多数卵巢癌患者化疗期间存在焦虑、抑郁不良情绪,且此不良心理状况与患者化疗后不良生存预后有关,提示医师应在化疗同时给予心理干预。
Objective To investigate and investigate the psychological status of patients with ovarian cancer during chemotherapy and its countermeasures. Methods The clinical data of 89 patients with ovarian cancer diagnosed and treated in Guangzhou Integrative Hospital from January 2011 to June 2013 were retrospectively analyzed. The anxiety status was evaluated by using anxiety self-rating scale (SAS) (SDS) were divided into anxiety group and group A according to the anxiety state, and divided into depression group and group B according to the state of depression and anxiety. The patients were followed up for 3 years, and the mental health and survival of all patients were statistically analyzed. Results In this survey, 62 patients with anxiety, anxiety rate was 69.63%, 49 patients with depression, the depression rate was 55.06%. The 3-year survival rate and median survival time were significantly lower in anxiety group than in group A , The difference was statistically significant (P <0.05). The 3-year survival rate and median survival time of depression group were significantly lower than those of B group, the difference was statistically significant (P <0.05). Conclusions Most ovarian cancer patients have anxiety and depression during chemotherapy, and this adverse psychological condition is related to the prognosis of poor survival after chemotherapy, suggesting that the physician should give psychological intervention at the same time of chemotherapy.